Literature DB >> 33171125

PD-L1 Blockade Therapy: Location, Location, Location.

Chrysothemis C Brown1, Jedd D Wolchok2.   

Abstract

The mechanisms by which PD-1/PD-L1 inhibition elicits anti-tumor immunity are not fully understood. In this issue of Cancer Cell, Dammeijer et al. address the role of PD-L1 inhibition specifically within the tumor-draining lymph node, identifying a potential role for PD-L1 expressing dendritic cells within the lymph node in regulation of anti-tumor immune responses.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33171125     DOI: 10.1016/j.ccell.2020.10.017

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  2 in total

1.  Endoglin-Aptamer-Functionalized Liposome-Equipped PD-1-Silenced T Cells Enhance Antitumoral Immunotherapeutic Effects.

Authors:  Shenxia Xie; Xiaoqiong Hou; Wei Yang; Wei Shi; Xiaomei Yang; Siliang Duan; Fengzhen Mo; Aiqun Liu; Wu Wang; Xiaoling Lu
Journal:  Int J Nanomedicine       Date:  2021-08-31

2.  Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapy.

Authors:  Hu Chen; Pengfei Zhang; Yesi Shi; Chao Liu; Qianqian Zhou; Yun Zeng; Hongwei Cheng; Qixuan Dai; Xing Gao; Xiaoyong Wang; Gang Liu
Journal:  J Nanobiotechnology       Date:  2022-02-02       Impact factor: 10.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.